SEGANA, LLC.

ORLANDO, FL · Founded 2020 · Medtech · Private

Cloud-based software platform enabling real-time adaptive radiation therapy dose delivery by analyzing daily anatomical changes to tumor location

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
ORLANDO, FL
Founded
2020
Latest Form D
$178K, Apr 2020
Total capital
$1.2M
Federal grants
$975K
2 awards · 2018–2019
Rank in peer group#50 of 51
Private capital raised
$178K
1 Form D · last Apr 2020
78 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201820192020FEDERAL ↑EQUITY ↓Cumulative $1.2M$225K$750K1st Form D$178K
201820192020FEDERAL ↑EQUITY ↓Cumulative $1.2M$225K$750K1st Form D$178K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$178K
  • Federal grantNSF · Phase II · SBIR Phase II: Cloud-based Automated Dose Accumulation for Online Adaptive Radiotherapy$750K
  • Federal grantNSF · Phase I · SBIR Phase I: Cloud-based Automated Dose Accumulation for Online Adaptive Radiotherapy$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

28months

from SEGANA, LLC.’s first federal award to its first private round.

First federal award · Jan 2018
NSF · $225K
First Form D · Apr 2020
$178K · 1st Form D
Awards before first raise
2 awards

An association in public records, not a cause or a prediction.

Standing among 51 peers

Line = median

Medtech · Software

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Rodney P. BosleyResearcherExecutive Officer, DirectorLinked by $975K in grants as PI
  • Anand SanthanamDirectorNamed in SEC Form D filings
  • Olusegun IlegbusiDirectorNamed in SEC Form D filings
  • Peter W. OsemoborDirectorNamed in SEC Form D filings
  • Rodney W. Bosley, Jr.Executive Officer, DirectorNamed in SEC Form D filings
  • Todd W. Andersen-DavisDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • UCHU BIOSENSORS, INC.Similar federal contract value in Medtech · null in contracts
  • RCE TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
  • COLOWRAP, LLCSimilar federal contract value in Medtech · null in contracts
  • Oxford Biodynamics PLCSimilar federal contract value in Medtech · null in contracts
  • X-SIGHT INCORPORATEDSimilar federal contract value in Medtech · null in contracts
  • QSM Diagnostics INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .